Levocetirizine + Capecitabine + Bevacizumab for Patients With Refractory Colorectal Cancer
Clinical trial NCT01722162 · COMPLETED
Trial details
- NCT number
- NCT01722162
- Sponsor
- Washington University School of Medicine
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2015-10-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.